Clinical Trials Browser

Phase 3 × Has announcements × Lymphoma, Large B-Cell, Diffuse × Clear all

NCT04404283 2026-04-20

ECHELON-3

Phase 3 Active not recruiting

239 enrolled 2 FDA

Lymphoma, Large B-Cell, Diffuse

NCT03274492 2026-02-06

POLARIX

Phase 3 Active not recruiting

1,000 enrolled 2 FDA

Lymphoma, Large B-Cell, Diffuse